The pancreatic beta cell regulates both the storage and metabolism of cellular fuels through secretion of insulin. Our studies and those of others have shown an enhanced number of beta cells in response to impaired tissue insulin sensitivity [1, 2] , a lowered betacell mass following partial pancreatectomy (Px) [3, 4] or hyperglycaemia [5, 6] . Beta-cell mass is determined by several factors including cell death and the recruitment of new cells by the replication of existing beta cells or by neogenesis from pancreatic ductal precursors [7] . The physiological regulation of these processes is not well understood; little is known in particular about the signalling mechanisms governing ductal proliferation, and subsequent endocrine differentiation and assembly into islets.
(IR) and post-receptor signalling cascade [1, 2, 8] . Heterozygous disruption of the IR and IRS-1 caused insulin resistance but diabetes was mild and late in onset because of a compensatory increase in betacell mass [1] . In contrast, homozygous null mutation of IRS-2 caused a similar insulin resistance but diabetes was severe and early in onset due to a lack of the beta-cell compensatory growth response [9] . This suggests that IRS-2, which was previously thought to act principally in the classical insulin-sensitive tissues such as liver, muscle, and adipose, must also play a crucial role in beta-cell compensatory growth. It is now clear that the IR [10] , IRS-1 [10±13] and IRS-2 [10,14±16] , and downstream components of the insulin signalling cascade are expressed in the beta cells [17±19] . Increased IRS-2 expression was found in beta-cell lines with enhanced proliferation capacity [14] and among ducts during pancreatic cancer [20] . Also, two key intermediates within the insulin signalling cascade, the lipid kinase phosphatidylinositol 3-kinase (PI3-kinase) and the growth factor-activated serine/threonine protein kinase B/Akt (Akt), are involved in regulating beta-cell proliferation and differentiation through IGF-I stimulation [17±20] . Furthermore, IGF-1-stimulated beta-cell proliferation is probably mediated through IRS-2 [15] . However, to date, there are few reports on endogenously-activated Akt within the pancreas.
Islet neogenesis, as a form of postnatal beta-cell growth, has been reported following a 90 %-Px in rats [4] . During the first week after surgery these rats not only showed the anticipated hyperplasia of islet beta cells but also the presence of proliferating ductal epithelium which subsequently differentiated and formed acini, ducts, and islets thus reiterating the pattern observed during embryogenesis [4] . Px-stimulated islet neogenesis has therapeutic potential, because an adequate amount of functional islet tissue can be restored following beta-cell ablation by streptozotocin [22] . It is not clear if IRS-2 or Akt is involved in this process .
We examined pancreatic remnants in rats 1, 2 and 5 days following a 60 %-Px to investigate potential roles for IRS-2 and Akt in the common duct where growth responses originate. These 60 %-Px rats display a similar regeneration sequence as that of the 90 %-Px rats but maintain normal plasma glucose concentrations making them an excellent model to investigate mechanisms of compensatory beta-cell adaptation [26, 27] .
Materials and methods
60 %-Px rat model. Male Sprague-Dawley rats (90±120 g) underwent a 60 %-Px using our method previously described [26] . We followed the principles of animal laboratory care strictly using the guidelines of both the NIH and UVM's Animal Care Committee. Briefly, the portion of the pancreas bordered by the spleen and stomach extending to the small flap attached to the pylorus was removed by gentle abrasion using cotton applicators. Rats were studied 1, 2 or 5 days post-surgery (unless stated otherwise) together with sham-operated control rats that had undergone laparotomy and mobilization of the pancreas on the same operation days. Body weight and non-fasting blood glucose concentrations were measured in rats before the Px surgery or sham surgery, and again on the day of study.
Tissue processing of pancreas for immunofluorescence. Px and sham pancreata (only the duodenal lobe of the shams was taken to ensure comparable anatomical areas) were rapidly excised and immersion-fixed overnight in 4.0 % paraformaldehyde in 0.1 mol/l PBS at 4 C. After washing in several changes of 0.1 mol/l PBS over 2 h at 4 C, tissues designated for IRS-2 staining were dehydrated in ascending ethanols and routinely infiltrated and embedded in paraffin. Five mm sections were mounted on charged microslides (Charge-Plus, Fisher Scientific, Pittsburgh, Penn., USA). For Akt staining, common pancreatic ducts were isolated by dissection from the whole pancreas under a stereoscope on ice and then paraformaldehyde-fixed. Duct tissue was washed and equilibrated in 30 % sucrose/PBS, embedded in O. C. T. medium (Miles Scientific, Elkhart, Ind., USA), and sectioned at 5 mm in a cryostat.
Multiple-labelling immunofluorescence. Hydrated sections of whole pancreas, or frozen sections of dissected common ducts were equilibrated in PBS. An antigen retrieval method was used for IRS-2 immunostaining (paraffin sections) that included a 10 min boil in 10 mmol/l sodium citrate or a 10 min incubation in 0.125 % trypsin at 37 C (Zymed Laboratories South San Francisco, Calif., USA) before blocking in 5 % normal donkey serum + 1 % BSA. Sections were incubated overnight at 40 C in various combinations of diluted rabbit antiserum raised against a GST-fusion peptide of mouse IRS-2
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[28], guinea pig anti-insulin (Linco Research, Charles, Mo., USA), and a nuclear counterstain,YoPro1 (0.5 m g/ml; Molecular Probes, Eugene, Ore., USA) or a proliferation marker (Ki-67 [29] ; PharminGen, San Diego, Calif., USA and PCNA [30] ; Zymed Laboratories) to label replicating cells. Immunostaining of frozen secretions for activated signalling intermediates was accomplished with a battery of phospho-specific antibodies to the MAPK family (including MAPK [Erk1/2], p38 MAPK, and SAPK/JNK) (Cell Signaling Technology, Beverly, Mass., USA). Activated Akt labelling used a mouse monoclonal anti-phospho-S 473 Akt (Cell Signaling Technology). Following washing, sections were incubated in a secondary antibody mixture that contained donkey anti-guinea pig CY2, donkey anti-rabbit CY2 or CY3 and donkey anti-mouse CY3 or CY5 (all from Jackson ImmunoResearch, Westgrove, Pa., USA) and mounted in Poly-AquaMount (Polysciences, Warrington, Pa., USA). Alternate sections were stained with either non-immune rabbit serum (replacing the IRS-2 antiserum in the series), normal donkey serum, or mouse monoclonal antibodies to irrelevant antigens. Controls for secondary antibody specificity were done as previously detailed [31] .
Confocal imaging. Sections were imaged using a Bio-Rad MRC 1024 (Hercules, Calif., USA) scanning confocal head coupled to an upright Olympus BX50 (Melville, NY, USA) microscope with an Ar-Kr laser utilizing the 488-, 568-, and 647 nm excitation lines (UVM Cell Imaging Facility). Images were acquired with the Bio-Rad LaserSharp software (v.3.2), merged and formatted on a Power Macintosh running Adobe Photoshop 5.0 (San Jose, Calif., USA).
Control experiments for IRS-2 and Akt expression. CHO cells that overexpress the human insulin receptor (CHO/IR) and mouse IRS-2 (CHO/IR/IRS-2) or rat Akt (CHO/IR/Akt) were grown in Ham's F-12 medium with 10 % fetal bovine serum [32] . Cells were grown overnight in DMEM (no serum) with 25 mmol/l glucose prior to stimulating with 100 nmol/l insulin. They were then rinsed and fixed in 4.0 % paraformaldehyde in 10 mmol/l PBS at room temperature for 30 min followed by immunofluorescence studies for IRS-2 and total Akt/phospho-Akt using the same protocol for the tissue sections. Alternatively, cells were lysed in the following buffer: 20 mmol/l Tris-HCl, pH 7.5, 137 mmol/l NaCl, 100 mmol/l NaF, 1 mmol/l MgCl 2 , 1 mmol/l CaCl 2 , 200 m mol/l sodium orthovanadate, 0.4 mmol/l PMSF, 50 mg/ml aprotinin, 50 mg/ml leupeptin, 10 % glycerol and 1 % NP-40 and centrifuged at 13 000 rpm for 15 min for immunoblot analyses.
Immunoblots were done using a variation of a previously described methods [32] . Isolated common pancreatic ducts were homogenized in 80 mmol/l HEPES, pH 7.4, 0.5 % NP40, 0.5 % Triton X-100, 5 mmol/l EDTA, 50 m g/ml leupeptin, 50 mg/ml aprotinin, 1 mmol/l phenylmethylsulfonylfluoride, and 200 mmol/l sodium orthovanadate, and centrifuged at 12 000 g for 15 min. Samples were heated at 95 C for 5 min in Laemmli sample buffer and aliquots run on 7.5 or 10 % SDS-PAGE, then transferred to nitrocellulose membranes. The IRS-2 immunoblots of the CHO lysates and duct homogenates were done with and without immunoprecipitation with rabbit anti-IRS-2 followed by probing with HRP-conjugated protein G (Calbiochem San Diego, Calif., USA) for 30 min. Total Akt and phospho-Akt levels were measured in duct supernatants and CHO lysates using a rabbit anti-Akt or mouse anti-phospho-S 473 Akt (Cell Signaling Technology) followed by incubation in either goat antirabbit-HRP or goat anti-mouse-HRP (Jackson ImmunoResearch). Following development with SuperSignal substrate (Pierce, Rockford, Ill., USA), bands were detected by exposure to BioMax MR film (Eastman-Kodak, Rockford, Ill., USA).
Quantification of IRS-2 in common duct epithelium.
A semiquantitative comparison of IRS-2 immunoreactivity in the common duct was accomplished by batch staining and sampling by confocal microscopy. Samples were imaged with the confocal microscope using a 60 PlanApo objective lens (N. A. = 1.4) and the 568 nm excitation line of a ArKr laser. For each field, the microscope was focused to maximize the number of common duct cells optically sectioned through the middle of the nucleus. All confocal imaging parameters were identical for each imaged field with 4±7 non-overlapping fields of about 190 190 mm captured for each Px and sham pancreas (n = 4 per group). Grayscale images (512´512 pixels) were transferred to a Power Macintosh G3 running NIH Image (v 1.62 NIH, USA) for image analysis. For each field studied, the Area-Measure tool was used to outline the entire epithelial sheet of the common duct (excluding goblet cells and luminal material), distinguishing between the main (luminal) lining and the adjacent blind evaginations. The mean pixel intensity (range = 0±255 grayscale levels) of the IRS-2 immunofluorescence was measured separately for the duct luminal lining and associated evaginations for each rat after subtraction of the field background fluorescence values.
Proliferation rates of the common duct epithelium. The relative numbers of common duct cells undergoing replication in the Px and sham rats were estimated by confocal imaging with the proliferation marker Ki-67 superimposed on a nuclear counterstain. The percentage of Ki-67 labelled duct cells was measured separately in the common duct lining and adjacent buds by counting an average of about 220 duct cells/pancreas (n = 4 per group).
Phospho-Akt and insulin in common duct epithelium. Using the same strategy as above, phospho-Akt was superimposed with a nuclear counterstain in frozen sections of isolated common ducts to determine the percentages of phospho-Akt-positive duct cells. Because epithelium from isolated common ducts was limited, the results are based on pooled data from 4±6 Px and sham rats to obtain approximately 875 cells for each group.
Results
General characteristics of 60 %-Px rats. The body weight and 0900 h plasma glucose concentrations of ad libitum fed 60 %-Px and sham-operated rats 1, 2 and 5 days post surgery are shown in Table 1 . Neither body weight nor plasma glucose concentrations were different in the Px and sham groups before surgery. Glycaemia did not change following the 60 %-Px surgery except for a minor increase at 2 days (p < 0.003 when pre surgery and 2-day post-Px glycaemia values in the same rats were compared using a paired Student's t test, and p < 0.01 when 2-day sham and 2-day Px rats were compared by unpaired Student's t test). Body weight decreased after the Px surgery but returned to normal growth rate by the second day. This finding agrees with our previous observations of normal to slightly subnormal body weights in 60 %-Px rats 3±6 weeks post surgery [26] .
Ductal hyperplasia and insulin expression in Px rats. There was a substantial increase in proliferation of the common duct epithelium after the 60 %-Px sur- Data are presented as means SEM. Rats underwent sham-Px or 60 %-Px as described in the text. Plasma glucose and body weight measurements were made on the morning of the surgery and again 1, 2 or 5 days after surgery; thus each post-surgery group is unique, with the number of animals in brackets.
a The absolute body weight is shown for the day of surgery. Thereafter, the data are expressed as delta body weight which was calculated as the weight on the day of study after surgery minus the weight of that rat on the day of surgery gery ( Fig. 1A, B) . The percentage of proliferating common duct cells was estimated using the proliferation marker Ki-67 and a nuclear counterstain (Fig. 1C) . At day 2 following the 60 %-Px, the proliferation rate of the duct luminal lining epithelium increased about fourfold in the Px rats compared with the sham-operated control rats (p = 0.024). No significant differences were observed between the Px and sham rats at 1 or 5-days after surgery (data not shown). Single endocrine cells, or endocrine cell clusters that expressed insulin and, less often, pancreatic polypeptide or glucagon, were found to be widely scattered among the epithelium of the common pancreatic duct and its lateral evaginations (see below). These hormone-positive cells were not unique to Px rats but were more frequently encountered in these than in the control rats. However, a meaningful statistical analysis was not possible because these cells were scattered so widely. Thus, both increased ductal proliferation and beta-cell neogenesis were observed in the common duct of 2-day post-Px rats. We then focused on the potential role of the insulin signalling pathway in these processes.
IRS-2 and Akt immunoreactivity in CHO cells. The specificity of the IRS-2 and Akt antibodies were tested in IRS-2-and Akt-overexpressing CHO/IR cells using immunofluorescence and immunoblot detection. The CHO/IR cells showed low endogenous IRS-2, Akt and phospho-Akt (Fig. 2) . But the expected increases in IRS-2 immunoreactivity in the CHO/ IR/IRS-2 cells ( Fig. 2A) and Akt immunoreactivity in CHO/IR/Akt cells (Fig. 2B ) could be clearly seen with both methods. After insulin stimulation, a marked increase in phosphorylated (activated) Akt immunoreactivity was observed using the phosphoAkt antibody which was at the correct molecular weight for Akt according to the immunoblot analysis ( Fig. 2C ) with no change in total Akt immunoreactivity.
IRS-2 in the common pancreatic ducts. We investigated IRS-2 expression in the common duct of 2-day Px rats using immunoblot and immunofluorescence. Immunoblot analysis of IRS-2 immunoprecipitates of dissected duct homogenates revealed a single band at the expected molecular mass of IRS-2 but no difference in band intensity between the Px and sham rats (data not shown). In contrast, IRS-2 immunofluorescence revealed a marked difference in signal intensity between the Px and sham rats 2 days after surgery at this same timepoint. Low to moderate IRS-2 staining intensity was evident in the duct epithelium of the control rats (Fig. 3A) as opposed to much higher IRS-2 staining intensity in Px rats (Fig. 3B) . Quantification of the IRS-2 staining intensity using batch staining and image analysis, selectively measuring only the ductal epithelium, showed a 1.71-fold (p = 0.013) and 1.83-fold (p = 0.008) increase in the 2-day Px group compared with sham group for the common duct luminal cells and budding evaginations, respectively (Fig. 3E) . The increase in IRS-2 immunostaining was specific to the common duct epithelium of Px rats 2 days after Px surgery, as adjacent acinar tissue (Fig. 3A,B) and small ducts showed equivalent low-intensity staining in both groups. Moreover, the IRS-2 signal was often intense in those duct cells that were proliferating, as shown by co-staining with a nuclear marker associated with replication (Fig. 3C) . Increases in IRS-2 staining was also observed in all single cells (Fig. 3D) or cell clusters that expressed insulin as well as islet beta cells (not shown). However, the virtual lack of staining with the proliferation marker, PCNA, suggests that these ductal insulin + /IRS-2 + cells were probably post-mitotic (Fig. 3D) . Hence, heightened IRS-2 immunostaining intensity was observed in the common duct epithelium in Px rats 2 days after surgery and was especially strong in all associated cells that expressed insulin, presumably nascent, differentiated beta cells.
Akt expression in ducts. We then investigated expression and activation of some candidate downstream intermediates of the insulin-receptor/IRS and growth factor cascades in dissected ducts from Px and sham rats 2 days after surgery. This was accomplished using phospho-specific antibodies against Akt and key members of the MAPK family (see Methods section). We could find no reproducible staining patterns in the duct epithelia with any of the phospho-MAPK antibodies in either the Px or sham rats. On the other hand, phospho-Akt immunoreactivity was markedly increased within the epithelia of common duct evaginations in the Px rats: while 9 % of these cells from control rats stained for phospho-Akt (Fig. 4A) , 32 % were immunopositive in the Px group (Fig. 4B) . Immunoblot analysis of duct homogenates for both phospho-and total Akt revealed about 60 kDa bands, the expected mass of Akt (not shown). In contrast to the normalization of common duct IRS-2 immunoreactivity at 5 days post-surgery, phospho-Akt staining (Fig. 4C ) in contrast to the mostly cytoplasmic pattern observed in the majority of the common duct epithelial cells. Phospho-Akt immunoreactivity did not correlate with proliferating duct cells, as suggested by the consistent lack of co-staining with proliferation markers (data not shown). Phospho-Akt immunoreactive cells also failed to stain for amylase and most were islet hormone-negative even 5 days after surgery, although some had modest levels of insulin immunopositivity (not shown). However, definitive insulin-positive cells were phospho-Akt-negative.
In contrast to activated Akt, immunostaining for total Akt resulted in a diffuse pattern of similar intensity in the ducts of sham and Px rats (not shown). Thus, phospho-Akt immunoreactivity marks specific non-proliferating cells of the evaginated common duct epithelium which have increased in number 2 days after Px surgery.
Discussion
Prompted by recent studies highlighting the importance of the insulin signalling pathway in beta-cell growth, maintenance and differentiation [1, 2, 8±16], we examined IRS-2 and activated Akt in situ in relation to early common duct epithelial proliferation and insulin expression in a genetically normal, nondiabetic model of pancreatic regeneration and betacell adaptation, the 60 % Px rat. Studies on IRS-2 knockout mice show an inadequate beta-cell compensatory growth response to increased insulin resistance indicating that IRS-2 has proliferation and survival roles in the beta cell [1, 8, 9] . However, it is not clear whether the loss of IRS-2 function affects these mice during fetal pancreatic islet development or postnatally or both. Because IRS-2 expression increases in highly proliferative beta-cell lines [14] and pancreatic tumors [20] , there is now evidence linking IRS-2 with mitogenic signalling in beta cells. Previous studies in animals and humans have found IRS-2-expression in the pancreatic duct epithelium [9, 20] , although the role of IRS-2 in regeneration and betacell neogenesis has not been directly addressed. Our results demonstrate that 60 %-Px rats show increased IRS-2 immunostaining in common duct epithelium which correlates with increased proliferation of this tissue, and that higher phospho-Akt levels are due to increased cell numbers with activated Akt staining among the common duct evaginations. Hence, both signalling proteins could function in mediating early events of pancreatic regeneration. However, whether these two proteins function independently or within a common signalling pathway remains an open question.
Following Px surgery, a very active replication of the common duct epithelium which correlated with enhanced IRS-2 immunoreactivity took place. Both events were short term and occurred over an identical timeframe. Surprisingly, of the three epithelial components of the pancreas (islet endocrine, acinar, and ducts), we could detect differences in IRS-2 immunoreactivity by semi-quantitative immunofluorescence only in the larger ducts 2 days following Px surgery. We observed about a 1.7-fold increase in IRS-2 immunoreactivity which coincided with a fourfold increase in proliferation in the common duct lining. Differences in IRS-2 levels in the common ducts among Px and control groups were not found using immunoblot because dissected duct preparations were not pure epithelial sheets but contained sub- stantial connective tissue and trace amounts of acinar tissue, both of which express IRS-2 by immunohistochemical detection. However, the significant increase in IRS-2 immunofluorescence signal corresponds with the short-lived proliferation ªburstº reported in the common ducts of the 90 %-Px rat model 36 h after surgery [4] . Interestingly, in this same model and timeframe, a short-term rise in IGF-I mRNA expression in the regenerating ductal epithelium has been observed [33] . Thus, following a partial pancreatectomy, locally-borne IGF-I might be the triggering ligand that initiates or increases the duct proliferation response or both through the IRS-2 pathway. Increased in IRS-2 levels 2 days after surgery further indicate that this site is the initial focus of regeneration [4] .
The epithelial lining of the pancreatic ducts serves as the source of exocrine and islet tissue during embryonic development, and, postnatally, during islet neogenesis which occurs less-frequently in the lifespan of the animal [7] . If a complete developmental recapitulation occurs during regeneration, then duct cells should serve as progenitors for all epithelium of the regenerating pancreas. However, within the narrow timeframe of the current study (1 to 5 days), we saw no evidence for acinar cell differentiation in the common ducts, as suggested by the observation that there were no amylase-positive cells among the duct epithelium. We did find increased but nevertheless low numbers of non-proliferating insulin-positive cells among the budding epithelium of Px rats which also showed strong IRS-2 immunoreactivity. Because all islet beta cells show cytoplasmic IRS-2 immunoreactivity [34] and our unpublished results), IRS-2 could have a maintenance role by promoting survival or the delay of apoptosis [1] .
IRS-2 staining increased in proliferating common duct epithelium following Px but phospho-Akt immunoreactivity was observed, in contrast, in distinct, non-replicating but closely-associated cells of the evaginations. In many duct cells with strong phospho-Akt staining, IRS-2 immunoreactivity showed no increase in intensity. Instead, a surface-oriented localization suggestive of an activated state associated with the plasma membrane was found. Future studies are needed to determine whether this IRS-2 staining pattern in duct cells correlates with enhanced IRS-2 phosphorylation/activation.
The precise functional roles of both PI3-kinase and Akt are still not clear although they have been linked to IGF-I-stimulated beta-cell replication [17±19] and mass expansion in vivo [21] . We found little or no phospho-Akt immunostaining in islets with hyperproliferating beta cells (data not shown) and we could not detect either differences in total Akt levels in islets or ducts between Px and sham-operated rats using immunostaining. The consistent observation of increased numbers of non-proliferating phospho-Akt + duct cells in Px rats 2 days after surgery could reflect enhanced insulin/growth factor signalling through this intermediate in certain duct cells. Some of these cells express low levels of insulin but not amylase suggesting that Akt could regulate differentiation signals, as opposed to its presumed role in beta-cell lines where Akt mediates proliferation from stimulation by insulin, IGF-I, or GLP-1 [18, 19] . It is not clear if these particular duct cells are betacell progenitors during regeneration.
There is some evidence that activated MAPKs can function in glucose-dependent, beta-cell activities [35±37] but their role in beta-cell growth and differentiation is not clear. We examined the expression of three activated MAPKs (including Erk1/2, p38 MAPK, and SAPK/JNK) using immunofluorescence and found no correlation with IRS-2 staining patterns in the pancreatic ducts. The IGF-I receptor [39] seems to be the most important of the three known insulin receptor-family tyrosine kinases on the surfaces of beta cells in mediating beta-cell compensatory growth and proliferation [1] , although the expression of these three receptors (insulin receptor [10±13], insulin receptor-related receptor [38] and the IGF-I receptor) in ducts of the adult pancreas has not been investigated.
Phospho-Akt immunostaining in the common duct epithelium was more extensive in Px rats than in the sham-operated control rats suggesting that specific duct cells show increased Akt signalling by 48 h after surgery. These cells were also present in the control rats, although in much smaller quantities (~30 % of Px value). Once activated, Akt translocates and is targeted to specific cellular domains to undertake a variety of functions such as the regulation of metabolism, suppression of apoptosis and control of translation and transcription (see [40±42] for recent reviews). We are currently exploring the possibility that activated Akt in ducts could target factors that regulate growth and survival or cell-specific gene expression, or both. Indeed, transgenic mice that overexpress a constitutively active Akt isoform driven by the insulin promoter were observed to have an eightfold increase in betacell mass [21] , although it is not clear whether beta-cell neogenesis increased in this model.
Conclusions.
Our results indicate that IRS-2 has multiple roles in influencing early regeneration events in the Px model. These include the proliferation of common duct cells, as well as the possible maturation of certain duct cells into beta cells or the maintenance of the differentiated beta-cell phenotype, or both. The restricted expression of activated-Akt to cells of the budding common duct epithelium suggests that Akt could function in pancreatic regeneration by providing signals which result in cell-specific gene expression or survival, possibly by signalling through IRS-2.
